The Jarring Contradiction at the Heart of RFK Jr.’s Agenda
The health secretary has begun a full-on assault against vaccines [...]
The health secretary has begun a full-on assault against vaccines [...]
FibroGen has agreed to pay $1.25 million to the Securities [...]
Capsida Biotherapeutics has paused a gene therapy clinical trial after [...]
LB Pharmaceuticals’ decision to break cover and go public seems [...]
The Danish drugmaker said it needed to streamline operations and [...]
Less than two years after breaking ground on a ballyhooed [...]
One week after warning that the United Kingdom is undervaluing [...]
The highly debatable HARMONi data, along with the trial design [...]
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are [...]
From now on, MEI Pharma—previously best known for its clinical-stage [...]